메뉴 건너뛰기




Volumn 31, Issue 1, 2012, Pages 163-167

Efficacy of leflunomide addition in relation to prognostic factors for patients with active early rheumatoid arthritis failing to methotrexate in daily practice

Author keywords

Anti TNF; Combination; DMARDs; Leflunomide; Methotrexate; Prognostic factors

Indexed keywords

LEFLUNOMIDE; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR;

EID: 84856715215     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1842-y     Document Type: Article
Times cited : (6)

References (12)
  • 2
    • 31044442965 scopus 로고    scopus 로고
    • The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    • DOI 10.1002/art.21519
    • FC Breedveld MH Weisman AF Kavanaugh SB Cohen K Pavelka R van Vollenhoven, et al. 2006 The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 54 26 37 16385520 10.1002/art.21519 1:CAS:528:DC%2BD28XhsVens74%3D (Pubitemid 43122183)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.1 , pp. 26-37
    • Breedveld, F.C.1    Weisman, M.H.2    Kavanaugh, A.F.3    Cohen, S.B.4    Pavelka, K.5    Van Vollenhoven, R.6    Sharp, J.7    Perez, J.L.8    Spencer-Green, G.T.9
  • 3
    • 48149100741 scopus 로고    scopus 로고
    • Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): A randomised, double-blind, parallel treatment trial
    • 18635256 10.1016/S0140-6736(08)61000-4 1:CAS:528:DC%2BD1cXpt1GqtLY%3D
    • P Emery FC Breedveld S Hall P Durez DJ Chang D Robertson, et al. 2008 Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial Lancet 372 375 382 18635256 10.1016/S0140-6736(08)61000-4 1:CAS:528:DC%2BD1cXpt1GqtLY%3D
    • (2008) Lancet , vol.372 , pp. 375-382
    • Emery, P.1    Breedveld, F.C.2    Hall, S.3    Durez, P.4    Chang, D.J.5    Robertson, D.6
  • 5
    • 0029022389 scopus 로고
    • Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis
    • for the Methotrexate-Cyclosporine Combination Study Group et al. 7791814 10.1056/NEJM199507203330301 1:STN:280:DyaK2Mzht1Sjug%3D%3D
    • P Tugwell T Pincus D Yocum M Stein O Gluck G Kraag for the Methotrexate-Cyclosporine Combination Study Group, et al. 1995 Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis N Engl J Med 333 137 141 7791814 10.1056/NEJM199507203330301 1:STN:280: DyaK2Mzht1Sjug%3D%3D
    • (1995) N Engl J Med , vol.333 , pp. 137-141
    • Tugwell, P.1    Pincus, T.2    Yocum, D.3    Stein, M.4    Gluck, O.5    Kraag, G.6
  • 7
    • 77953696525 scopus 로고    scopus 로고
    • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
    • 20444750 10.1136/ard.2009.126532 1:CAS:528:DC%2BC3cXos1GiurY%3D
    • JS Smolen R Landewé FC Breedveld M Dougados P Emery C Gaujoux-Viala, et al. 2010 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs Ann Rheum Dis 69 964 975 20444750 10.1136/ard.2009.126532 1:CAS:528:DC%2BC3cXos1GiurY%3D
    • (2010) Ann Rheum Dis , vol.69 , pp. 964-975
    • Smolen, J.S.1    Landewé, R.2    Breedveld, F.C.3    Dougados, M.4    Emery, P.5    Gaujoux-Viala, C.6
  • 8
    • 43049158205 scopus 로고    scopus 로고
    • Clinical identification and treatment of rapidly progressing disease state in patients with rheumatoid arthritis
    • 18094000 10.1093/rheumatology/kem257 1:CAS:528:DC%2BD1cXmslKhtro%3D
    • P Emery IB McInnes R van Vollenhoven MC Kraan 2008 Clinical identification and treatment of rapidly progressing disease state in patients with rheumatoid arthritis Rheumatology 47 392 398 18094000 10.1093/rheumatology/ kem257 1:CAS:528:DC%2BD1cXmslKhtro%3D
    • (2008) Rheumatology , vol.47 , pp. 392-398
    • Emery, P.1    McInnes, I.B.2    Van Vollenhoven, R.3    Kraan, M.C.4
  • 9
    • 68049124945 scopus 로고    scopus 로고
    • Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
    • 19665644 10.1016/S0140-6736(09)60944-2
    • RF van Vollenhoven S Ernestam P Geborek IF Petersson L Cöster E Waltbrand, et al. 2009 Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial Lancet 374 459 466 19665644 10.1016/S0140-6736(09)60944-2
    • (2009) Lancet , vol.374 , pp. 459-466
    • Van Vollenhoven, R.F.1    Ernestam, S.2    Geborek, P.3    Petersson, I.F.4    Cöster, L.5    Waltbrand, E.6
  • 11
    • 43949125192 scopus 로고    scopus 로고
    • Triple therapy in early active rheumatoid arthritis: A randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies
    • DOI 10.1002/art.23449
    • SA Saunders HA Capell A Stirling R Vallance W Kincaid AD McMahon, et al. 2008 Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies Arthritis Rheum 58 1310 1317 18438851 10.1002/art.23449 1:CAS:528:DC%2BD1cXms1ehu7o%3D (Pubitemid 351705920)
    • (2008) Arthritis and Rheumatism , vol.58 , Issue.5 , pp. 1310-1317
    • Saunders, S.A.1    Capell, H.A.2    Stirling, A.3    Vallance, R.4    Kincaid, W.5    McMahon, A.D.6    Porter, D.R.7
  • 12
    • 73349096059 scopus 로고    scopus 로고
    • Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: Data from the QUEPARD trial
    • 19741011 10.1093/rheumatology/kep261 1:CAS:528:DC%2BC3cXksVyhuw%3D%3D
    • M Soubrier X Puéchal J Sibilia X Mariette O Meyer B Combe, et al. 2009 Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the QUEPARD trial Rheumatology 48 1429 1434 19741011 10.1093/rheumatology/kep261 1:CAS:528:DC%2BC3cXksVyhuw%3D%3D
    • (2009) Rheumatology , vol.48 , pp. 1429-1434
    • Soubrier, M.1    Puéchal, X.2    Sibilia, J.3    Mariette, X.4    Meyer, O.5    Combe, B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.